Article info

Download PDFPDF
Lack of evidence for a link between latanoprost use and malignant melanoma: an analysis of safety databases and a review of the literature
  1. Correspondence to Charles S Tressler, Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA; charles.s.tressler{at}pfizer.com
View Full Text

Citation

Tressler CS, Wiseman RL, Dombi TM, et al
Lack of evidence for a link between latanoprost use and malignant melanoma: an analysis of safety databases and a review of the literature

Publication history

  • Accepted March 20, 2011
  • First published April 21, 2011.
Online issue publication 
March 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.